Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct

NCT ID: NCT01499537

Last Updated: 2016-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At this time, endoscopic retrograde cholangiopancreatography (ERCP) stay the gold standard method to achieve biliary drainage in case of malignant or benign stricture. When ERCP fail or if the major papilla is not suitable, percutaneous transhepatic biliary drainage (PTBD) is the most commonly used alternative, surgery having higher morbidity and mortality rates, unacceptable especially in palliative situation. Recent developments in interventional endoscopic ultrasonography (EUS) allow new endoluminal approaches to pancreatic-biliary structures, such as cysto-enterostomy or pancreatic-enterostomy. More recently were described the possibility to realize EUS-guided biliary drainage, through the duodenal or the gastric wall. Advantages of the EUS-guided approach are to be realizable even the papilla is not suitable endoscopically (duodenal stricture or post-surgical status) and to allow if necessary extra-tumoral non anatomic drainage (hepaticogastrostomy). This technique is actually an alternative to PTBD. In comparison of the PTBD, EUS-guided route seems to have less morbidity and to avoid external biliary drainage. Indeed, the morbidity rate of the percutaneous biliary drainage and the EUS-guided biliary drainage range respectively from 25 to 35% and from 0 to 23%. However, none study compare prospectively both techniques. Aims of this study are to compare the morbidity rate, feasibility and efficacy of these techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Jaundice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Percutaneous Drainage

Percutaneous Transhepatic Biliary Drainage (PTBD)

Group Type ACTIVE_COMPARATOR

biliary drainage

Intervention Type DEVICE

percutaneous transhepatic biliary drainage (PTBD)

EUS-guided drainage

endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall

Group Type EXPERIMENTAL

EUS guided biliary drainage

Intervention Type DEVICE

endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

biliary drainage

percutaneous transhepatic biliary drainage (PTBD)

Intervention Type DEVICE

EUS guided biliary drainage

endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \>= 18
* Karnofsky \>= 50%
* biliary stenosis (malignant or benign stricture)with failure of endoscopic retrograde cholangiopancreatography
* signed informed consent

Exclusion Criteria

* isolated biliary stenosis of right hepatic canal
* percutaneous biliary drainage \< 10 days
* laparotomy \< 10 days
* contra-indication to the procedure
* pregnant women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Paoli-Calmettes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erwan BORIES, MD

Role: PRINCIPAL_INVESTIGATOR

Institut Paoli-Calmettes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Paoli-Calmettes

Marseille, , France

Site Status

Hopital Nord

Marseille, , France

Site Status

Centre Hospitalier Princesse Grace

Monaco, , Monaco

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France Monaco

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHAGE/IPC 2010-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EUS Biliary Drainage vs. ERCP
NCT03870386 COMPLETED NA